Biocon falls over 10% in five trading days

The stock dipped 5% to Rs 1,031, extending its 6.8% decline in past four trading days on the BSE.

Biocon dipped 5% to Rs 1,031, extending its 6.8% decline in past four trading days on the BSE.  In comparison, the benchmark S&P BSE Sensex gained marginally by 0.03% during the same period.

Biocon posted muted growth during the March 2017 (Q4FY17) quarter on the back of weak performance in small molecules and decline in Syngene sales. Total sales of the company during the quarter declined 2% year on year (Y-o-Y) at Rs 925 crore.

Net profit after exceptional item was down 62% YoY at Rs 127 crore. The exceptional income of Rs 256 crore in Q4FY16 was